Literature DB >> 8725863

The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men.

A Tchernof1, B Lamarche, D Prud'Homme, A Nadeau, S Moorjani, F Labrie, P J Lupien, J P Després.   

Abstract

OBJECTIVE: To investigate the potential relationship between the cluster of metabolic abnormalities found in visceral obesity and the small dense LDL phenotype. RESEARCH DESIGN AND METHODS: We have estimated LDL peak particle size by nondenaturing 2-16% gradient gel electrophoresis in a sample of 79 men. Glucose tolerance and fasting plasma insulin and lipoprotein levels were also measured.
RESULTS: The LDL particle score, calculated from migration, distances and relative band intensities and reflecting the proportion of small dense LDL particles, was positively correlated with plasma triglyceride (TG) (r = 0.60, P < 0.0001) and negatively correlated with HDL cholesterol (r = -0.56, P < 0.0001) levels. Although the LDL particle score was not associated with variations in plasma LDL cholesterol or LDL apolipoprotein (apo) B concentrations, it was significantly correlated with the LDL apo B-to-LDL cholesterol ratio (r = 0.60, P < 0.0001). Fasting plasma insulin and visceral adipose tissue (AT) areas measured by computed tomography were weakly but significantly correlated with the LDL particle score (r = 0.23 and 0.29, respectively, P < 0.05). LDL peak particle size showed similar but inverse correlations with anthropometric and metabolic variables. Subjects classified as having small dense LDL particles (by comparing subjects in the highest tertile versus those in the lowest tertile of the LDL particle score distribution) were characterized by increased plasma TG, reduced HDL cholesterol, higher fasting insulin levels, and elevated visceral AT accumulation. However, multiple regression analyses revealed that visceral AT accumulation was not an independent predictor of the dense LDL phenotype after inclusion of TG and HDL cholesterol levels and lipoprotein ratios in the model.
CONCLUSIONS: It thus appears that the high TG-low HDL cholesterol dyslipidemia frequently found in visceral obesity and in a hyperinsulinemic state is a strong correlate of the small dense LDL phenotype. Although associated with the dense LDL phenotype, visceral obesity and hyperinsulinemia were not independent predictors of an increased proportion of small dense LDL particles after controlling for TG and HDL cholesterol levels.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8725863     DOI: 10.2337/diacare.19.6.629

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  41 in total

1.  Abdominal obesity and the "hypertriglyceridaemic waist" phenotype.

Authors:  P Little; C D Byrne
Journal:  BMJ       Date:  2001-03-24

2.  Drug treatment for obesity. We need more studies in men at higher risk of coronary events.

Authors:  J P Després
Journal:  BMJ       Date:  2001-06-09

Review 3.  Obesity, hypertension, and vascular disease.

Authors:  K M Sowers; J R Sowers
Journal:  Curr Hypertens Rep       Date:  1999 Apr-May       Impact factor: 5.369

Review 4.  Abdominal adipose tissue distribution and metabolic risk.

Authors:  Suzy Wong; Ian Janssen; Robert Ross
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

Review 5.  Metabolic pathogenesis of familial combined hyperlipidaemia with emphasis on insulin resistance, adipose tissue metabolism and free fatty acids.

Authors:  Jacqueline de Graaf; Mario J Veerkamp; Anton F H Stalenhoef
Journal:  J R Soc Med       Date:  2002       Impact factor: 5.344

6.  Proteasome activity correlates with male BMI and contributes to the differentiation of adipocyte in hADSC.

Authors:  Kozue Sakamoto; Youichi Sato; Masako Sei; Ashraf A Ewis; Yutaka Nakahori
Journal:  Endocrine       Date:  2010-01-05       Impact factor: 3.633

7.  Much lower prevalence of coronary calcium detected by electron-beam computed tomography among men aged 40-49 in Japan than in the US, despite a less favorable profile of major risk factors.

Authors:  Akira Sekikawa; Hirotsugu Ueshima; Wahid Riad Zaky; Takashi Kadowaki; Daniel Edmundowicz; Tomonori Okamura; Kim Sutton-Tyrrell; Yasuyuki Nakamura; Katsuya Egawa; Hideyuki Kanda; Atsunori Kashiwagi; Yoshiyuki Kita; Hiroshi Maegawa; Kenichi Mitsunami; Kiyoshi Murata; Yoshihiko Nishio; Shinji Tamaki; Yoshiki Ueno; Lewis H Kuller
Journal:  Int J Epidemiol       Date:  2004-11-24       Impact factor: 7.196

Review 8.  The metabolic syndrome.

Authors:  O Bosello; M Zamboni
Journal:  Eat Weight Disord       Date:  2002-06       Impact factor: 4.652

9.  Lipoprint adequately estimates LDL size distribution, but not absolute size, versus polyacrylamide gradient gel electrophoresis.

Authors:  Krista A Varady; Benoît Lamarche
Journal:  Lipids       Date:  2011-09-21       Impact factor: 1.880

Review 10.  Fat fibrosis: friend or foe?

Authors:  Ritwik Datta; Michael J Podolsky; Kamran Atabai
Journal:  JCI Insight       Date:  2018-10-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.